Literature DB >> 16817286

Is body surface area still the best way to determine pump flow rate during cardiopulmonary bypass?

R Peter Alston1, Anna Anderson, Keith Sanger.   

Abstract

For over four decades, pump flow rate during cardiopulmonary bypass (CPB) has been estimated using body surface area (BSA). As patients presenting for heart surgery are increasingly obese, this approach may no longer be appropriate and other estimates of systemic metabolism should be used, such as body mass index and lean body mass. Mixed venous oxygen saturation (SvO2) is a robust and independent estimate of the global efficacy of CPB. The aim of this study was to determine which factors, including body surface area, body mass index and lean body mass, best predict SvO2 during CPB. Forty-eight patients undergoing elective cardiac surgery requiring CPB were studied. Patients' height, weight and skinfold thickness at four sites (biceps, triceps, subscapularis and suprailiac) were measured. Body surface area, lean body mass and body mass index were then calculated. Pump flow rate was maintained at 2.4 L/min/ m2 during CPB as per standard unit protocol. Arterial and mixed venous blood samples were taken during the cooling, stable hypothermia and rewarming phases of CPB. Nasopharyngeal temperatures and flow rates were recorded contemporaneously. The blood samples were analysed for oxygen saturation, haemoglobin concentration and partial pressures of oxygen and carbon dioxide. The values of the three time points were meaned. All potential predictor variables were then univariately correlated with mixed venous oxygen saturation (SvO2). Those correlating significantly (p < 0.1) were entered into a multivariate linear regression model. Nasopharyngeal temperature (beta = 0.615, p < 0.001) and lean body mass (beta = 0.256, p < 0.028) were the only significant predictors of SvO2 (r2 = 0.433, p2 < 0.001). Pump flow rates maintained at 2.4 L/min/m2 throughout CPB results in relative over-perfusion during hypothermia. Lean body mass may be a more sensitive estimate of systemic metabolism and, therefore, may provide a more accurate means of determining pump flow rate than body surface area in patients undergoing heart surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16817286     DOI: 10.1191/0267659106pf865oa

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  6 in total

1.  Going beyond manufacturers' limitations is not in the best interest of our patients.

Authors:  Gerard J Myers
Journal:  J Extra Corpor Technol       Date:  2014-03

2.  Lean Flow: Optimizing Cardiopulmonary Bypass Equipment and Flow for Obese Patients-A Technique Article.

Authors:  Joshua M Blessing; Jeffrey B Riley
Journal:  J Extra Corpor Technol       Date:  2017-03

3.  Red blood cell transfusion for infants with single-ventricle physiology.

Authors:  James A Kuo; Kevin O Maher; Paul M Kirshbom; William T Mahle
Journal:  Pediatr Cardiol       Date:  2011-02-18       Impact factor: 1.655

4.  Emergent cardiopulmonary bypass for a 180 kilogram patient: support with a single oxygenator.

Authors:  Kyler T Hunter; Angela R Lopez; Kwok L Yun
Journal:  J Extra Corpor Technol       Date:  2013-09

5.  Prescriptive patient extracorporeal circuit and oxygenator sizing reduces hemodilution and allogeneic blood product transfusion during adult cardiac surgery.

Authors:  Shahna L Bronson; Jeffrey B Riley; Joshua P Blessing; Mark H Ereth; Joseph A Dearani
Journal:  J Extra Corpor Technol       Date:  2013-09

6.  Ghrelin Pre-treatment Attenuates Local Oxidative Stress and End Organ Damage During Cardiopulmonary Bypass in Anesthetized Rats.

Authors:  Vijayakumar Sukumaran; Hirotsugu Tsuchimochi; Yutaka Fujii; Hiroshi Hosoda; Kenji Kangawa; Tsuyoshi Akiyama; Mikiyasu Shirai; Eisuke Tatsumi; James T Pearson
Journal:  Front Physiol       Date:  2018-03-09       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.